Global Pathology Instruments Market Expected to Reach $6.2 Billion by 2030 with a 5.6% CAGR, Fueled by the Rise in Chronic Diseases and Growing Investments in Health Systems
Thursday, October 26, 2023
DUBLIN, Oct. 18, 2023 /PRNewswire/ -- The "Pathology Instruments - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global pathology instruments market, valued at US$4 billion in 2022, is set for substantial expansion, projected to reach an impressive size of US$6.2 billion by 2030. This growth is anticipated to occur at a steady compound annual growth rate (CAGR) of 5.6% during the analysis period of 2022-2030. Notably, specific segments within the market are also expected to thrive.
Molecular Diagnostics to Lead with a 7.1% CAGR, Reaching US$1.7 Billion
Among the segments analyzed in the report, Molecular Diagnostics stands out with a projected compound annual growth rate (CAGR) of 7.1%, reaching a substantial market size of US$1.7 billion by the end of the analysis period.
Strong Growth in Immunoassays Technology Segment with a 5.2% CAGR
The Immunoassays Technology segment is estimated to achieve steady growth with a CAGR of 5.2% over the next 8 years.
U.S. Market Estimated at $1.5 Billion, China Forecasted to Grow at 9.1% CAGR
In the United States, the pathology instruments market is estimated to be worth US$1.5 billion in 2022. Meanwhile, China, as the world's second-largest economy, is forecasted to experience significant growth, with a projected market size of US$603.8 million by 2030, boasting an impressive CAGR of 9.1% from 2022 to 2030.
Other Noteworthy Geographic Markets
In addition to China and the United States, several other geographic markets exhibit notable growth potential. Japan and Canada are each forecasted to grow at rates of 3.5% and 5.4%, respectively, over the 2022-2030 period. In Europe, Germany is expected to achieve approximately 4.8% CAGR. The Asia-Pacific region, led by countries such as Australia, India, and South Korea, is set to reach US$698.4 million by the year 2030.
Key Competitors in the Pathology Instruments Market
The following companies are at the forefront of the pathology instruments market:
-- Abbott Laboratories
-- Agilent Technologies, Inc.
-- Danaher Corporation
-- F. Hoffmann-La Roche AG
-- PerkinElmer, Inc.
-- Thermo Fisher Scientific, Inc.
Economic Outlook and Market Sentiments
The global economic outlook is showing signs of improvement, with growth recovery anticipated in the near future. While challenges persist, including inflation concerns, governments are actively addressing these issues. The rise of new technologies, such as AI, machine learning, and renewable energy, is expected to drive growth and add value to the global GDP.
Despite short-term challenges, businesses and leaders who demonstrate resilience and adaptability will find opportunities in this evolving landscape.
What`s New?
-- Special discussions on the global economic climate and market sentiment
-- Coverage on global competitiveness and key competitor percentage market
shares
-- Market presence analysis across multiple geographies -
Strong/Active/Niche/Trivial
-- Online interactive peer-to-peer collaborative bespoke updates
-- Access to digital archives and research platform
-- Complimentary updates for one year
-- Access to curated YouTube video transcripts of market sentiments shared
by CEOs, domain experts and market influencers via interviews, podcasts,
press statements and event keynotes
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
-- Pathology: The Silent Pillar of Modern Medicine's Evolution
-- Global Economic Update
-- Although Declining for the First Time Since the Russia-Ukraine War,
Global Oil Prices Still Remains Higher Than 2019 Levels Which In Turn
Will Take Inflation Longer Than Expected to Fall: Global Average Annual
Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2024
-- Slower Than Anticipated Decline Makes Inflation a Stickier Than Expected
Problem to Solve in 2023: Global Inflation Rates (In %) for the Years
2019 through 2024
-- Global Economy Faces a Tough Climb Towards Recovery Made Rockier by the
War, Persistent Challenges & Slower Decline in Underlying Core
Inflation: World Economic Growth Projections (Real GDP, Annual % Change)
for the Years 2020 Through 2024
-- Inflation Battling Policy Measures to Slowdown Post Pandemic Recovery in
Unemployment Rates: Global Number of Unemployed People (In Million) for
Years 2019 Through 2024
-- Competition
-- Pathology Instruments - Global Key Competitors Percentage Market Share
in 2023 (E)
-- Competitive Market Presence - Strong/Active/Niche/Trivial for Players
Worldwide in 2023 (E)
-- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
-- Rise in Chronic/Infectious Diseases Drives Demand for Pathology
Instruments in Clinical Chemistry & Diagnostics
-- Rising Prevalence of Chronic/Infectious Diseases Drives Demand for
Pathology Instruments & Devices Powering Modern Diagnostics: Global Cost
of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027,
2029 and 2031
-- Global Investments in Health Systems to Benefit Market Growth
-- Rise of Molecular Diagnostics to Drive a Large Chunk of Growth in the
Pathology Instruments Market
-- Robust Growth of Molecular Diagnostics Services Expands the Opportunity
Avenue for Pathology Instruments: Global Market for Molecular
Diagnostics (In US$ Million) for Years 2023, 2025 and 2027
-- Growing Role of Pathology in Drug Development to Spur Demand for
Pathology Instruments
-- From Microscope to Market, Pathology's Pivotal Role in Drug Evolution
Cannot be Undermined: Global Market for Drug Discovery (In US$ Billion)
for Years 2023, 2025, 2027, 2029 and 2031
-- Rising Importance of Forensic Pathology to Spur Demand for Pathology
Instruments
-- Growing Demand for Forensic Technologies & Services Translates Directly
into Increased Sales of Pathology Instruments: Global Market for
Forensic Technologies & Services (In US$ Million) for Years 2023, 2025,
2027 and 2029
-- Immunoassays Remain the Technology of Choice in the Field of Pathology
-- Impact of AI on Pathology Instruments
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/dpkqhm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-pathology-instruments-market-expected-to-reach-6-2-billion-by-2030-with-a-5-6-cagr-fueled-by-the-rise-in-chronic-diseases-and-growing-investments-in-health-systems-301960487.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
